Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art

SIMPLE SUMMARY: Over the disease course of metastatic prostate cancer, approximately the 90% of patients develops bone metastases, with bone involvement frequently leading to various skeletal complications including pathological fractures, spinal cord compression, and pain. Notably enough, the pecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Mollica, Veronica, Rizzo, Alessandro, Rosellini, Matteo, Marchetti, Andrea, Ricci, Angela Dalia, Cimadamore, Alessia, Scarpelli, Marina, Bonucci, Chiara, Andrini, Elisa, Errani, Costantino, Santoni, Matteo, Montironi, Rodolfo, Massari, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867059/
https://www.ncbi.nlm.nih.gov/pubmed/33535541
http://dx.doi.org/10.3390/cancers13030546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867059/
https://www.ncbi.nlm.nih.gov/pubmed/33535541
http://dx.doi.org/10.3390/cancers13030546

Ejemplares similares